Investigating the symptomatic and morphological changes in the brain based on pre and post-treatment: A critical review from clinical to neuroimaging studies on schizophrenia
- PMID: 37388500
- PMCID: PMC10300448
- DOI: 10.1016/j.ibneur.2023.03.008
Investigating the symptomatic and morphological changes in the brain based on pre and post-treatment: A critical review from clinical to neuroimaging studies on schizophrenia
Abstract
Pharmacological treatment for schizophrenia has been a long-standing concern. As a severe neuropsychological illness, schizophrenia is always a challenging disorder to unravel its pathophysiology. Since it exhibits both positive and negative symptoms, such as hallucination and delusion, as well as social isolation and cognitive impairment, following the symptomatic changes is a crucial task for clinicians. Although various pharmacological treatments are available in the form of antipsychotics, however, their actual consequences need to be examined with the observable changes in symptoms as well as the unobservable changes in brain functioning. This study is a first of its kind to critically investigate both clinical and neuroimaging studies to find out the changes being observed in schizophrenia patients after clinical intervention with various antipsychotics. We observed several symptomatic changes being reported in clinical studies incorporating clinical trials of various first-generation and second-generation antipsychotic drugs. Alongside, we encapsulated several neuroimaging studies showing functional and structural changes in the brain of schizophrenia patients triggered by a variety of drugs. The basal ganglia, frontal lobe, temporal lobe, cuneus, and middle occipital gyrus are some of the notable brain regions that were observed to show subtle functional and structural changes. This critical review paper may pave the way for future research into the study of the pathological and morphological changes in the brains of schizophrenia patients as they progress through the course of medicinal therapy.
Keywords: Clinical Intervention; Functional Changes; Neuroimaging; Pharmacology; Schizophrenia; Structural Changes; Symptoms.
© 2023 The Authors.
Conflict of interest statement
The authors have no conflict of interest.
Figures

Similar articles
-
[Cognition, schizophrenia and the effect of antipsychotics].Encephale. 2006 May-Jun;32(3 Pt 1):341-50. doi: 10.1016/s0013-7006(06)76162-0. Encephale. 2006. PMID: 16840928 Review. French.
-
[Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].Encephale. 2001 Sep-Oct;27(5):405-15. Encephale. 2001. PMID: 11760690 Review. French.
-
[Psychopathology of schizophrenia and brain imaging].Fortschr Neurol Psychiatr. 2008 May;76 Suppl 1:S49-56. doi: 10.1055/s-2008-1038152. Fortschr Neurol Psychiatr. 2008. PMID: 18461545 Review. German.
-
Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics.Front Psychiatry. 2021 Nov 30;12:735623. doi: 10.3389/fpsyt.2021.735623. eCollection 2021. Front Psychiatry. 2021. PMID: 34916969 Free PMC article.
-
Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis.BMC Psychiatry. 2013 Dec 20;13:342. doi: 10.1186/1471-244X-13-342. BMC Psychiatry. 2013. PMID: 24359128 Free PMC article.
Cited by
-
Imaging Transcriptomics of the Brain for Schizophrenia.Alpha Psychiatry. 2024 Jan 1;25(1):9-14. doi: 10.5152/alphapsychiatry.2024.231369. eCollection 2024 Jan. Alpha Psychiatry. 2024. PMID: 38799487 Free PMC article. Review.
-
Detection of brain regions responsible for chronic pain in osteoarthritis: an fMRI-based neuroimaging study using deep learning.Front Neurol. 2023 Jun 2;14:1195923. doi: 10.3389/fneur.2023.1195923. eCollection 2023. Front Neurol. 2023. PMID: 37333009 Free PMC article.
-
Patricia Goldman-Rakic: a pioneer and leader in frontal lobe research.Front Hum Neurosci. 2024 Jan 29;17:1334264. doi: 10.3389/fnhum.2023.1334264. eCollection 2023. Front Hum Neurosci. 2024. PMID: 38348372 Free PMC article. Review.
-
Neuroprotective effects of alpha-pinene against behavioral deficits in ketamine-induced mice model of schizophrenia: Focusing on oxidative stress status.IBRO Neurosci Rep. 2024 Jan 4;16:182-189. doi: 10.1016/j.ibneur.2023.12.012. eCollection 2024 Jun. IBRO Neurosci Rep. 2024. PMID: 38318342 Free PMC article.
-
Beyond pills and prescriptions: Exploring aging-related diseases with non-pharmacological strategies and molecular innovations.Aging Dis. 2025 Feb 20;16(4):1878-1888. doi: 10.14336/AD.2024.0560. Aging Dis. 2025. PMID: 40072368 Free PMC article. Review.
References
-
- American Psychiatric Association . Schizophrenia and other psychotic disorders. 5th ed. American Psychiatric Association; Washington, DC: 2013. Diagnostic and Statistical Manual of Mental Disorders; pp. 89–122.
-
- Astrup C., Noreik K.: Functional Psychoses: Diagnostic and Prognostic Models. Springfield, Ill, Charles. Thomas, 196634.
-
- Baaré W.F., van Oel C.J., Hulshoff Pol H.E., et al. Volumes of brain structures in twins discordant for schizophrenia. Arch. Gen. Psychiatry. 2001;58:33–40. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials